Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2016

View Archived Issues

BL-84, a genetically optimized banana lectin for influenza

FVM-04 neutralizes EBOV and SUDV in animal models

FDA accepts NanoCor's IND for Carfostin

Hummingbird Bioscience and Sanofi collaborate to develop therapeutic antibodies for cancer

Classic galactosemia animal model mimics human cerebral ataxia symptoms

Chugai Pharmaceutical updates pipeline activities of first quarter 2016

H. Lundbeck patents PDE1 inhibitors

RespiVert and Topivert Pharma disclose p38 kinase inhibitors

GlaxoSmithKline and New York University describe antiprotozoal agents

New probiotic reverses minimal hepatic encephalopathy

Alligator Bioscience receives milestone payment from Johnson & Johnson for ADC-1013 project

hVIVO reports favorable initial data from phase IIa study of PrEP-001 in influenza

Ascentage and Unity Biotechnology collaborate on senolytic therapies for age-related disease

Clusterin shows promise as a therapeutic target and biomarker in osteoporosis

FDA accepts for review Lundbeck's NDA resubmission for intravenous carbamazepine

Allergan acquires Topokine Therapeutics

Immune Therapeutics signs letter of intent to acquire Chinese CAR-T cocktail therapy

Sobi exercises IL-1 licensing agreement option with Affibody

Cold Spring Harbor Laboratory launches Center for Therapeutics Research project

E.U. grant supports PRECIOUS consortium's work on immunotherapeutic nanomedicines

NICE final guidance recommends use of cabazitaxel in England

Patiromer MAA submitted in E.U.

First joint research projects announced under NYU Langone and Technion collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...